Pharm.Assy SPRL
1.0 FTEPharm.Assy reported total assets of 268,957 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 1 full-time equivalent.
The score of Pharm.Assy shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +108 % Total assets +1 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharm.Assy's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 25,201 € | ||||
| Equity | 149,646 € | ||||
| Cash | 47,416 € | ||||
| EBITDA | 67,929 € | ||||
| Total assets | 268,957 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 08 Jul 2024
- Year ended 31 Dec 2022filed on 21 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Pharm.Assy's financial analysis
- Solvency55.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharm.Assy
Pharm.Assy's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0689.606.850
- VAT number
- BE0689606850
- Peppol
- Registered · 0208:0689606850 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 31 Jan 2018
- Registered office
- 1780 Wemmel
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharm.Assy (SPRL) has been based in Wemmel since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 25,201 € and equity of 149,646 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 55.6%, above the median of its sector (44.2%).
Companies similar to Pharm.Assy
Companies in the same business, of comparable size and area, outside its group.
- Maxipharma Retail sale of pharmaceutical products Charleroi · balance sheet 269,211 €
- Apotheek Haegemans - Mertens Retail sale of pharmaceutical products Herent · balance sheet 268,422 €
- De Baere OLV Retail sale of pharmaceutical products Roosdaal · balance sheet 269,784 €
- Pharmacie Boden Retail sale of pharmaceutical products Seraing · balance sheet 267,278 €
- Tripharma Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 266,344 €
- Gezondheidscentrum Vlierbeek Retail sale of pharmaceutical products Holsbeek · balance sheet 273,099 €
- Pharmacy Ghent Retail sale of pharmaceutical products Ghent · balance sheet 273,292 €
- Apoteek Brichau Retail sale of pharmaceutical products Halle · balance sheet 263,690 €
Frequently asked questions about Pharm.Assy
What is the revenue of Pharm.Assy?
Pharm.Assy files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharm.Assy?
In Belgium, the VAT number is the company number prefixed with BE: BE0689606850 for Pharm.Assy, if the company is VAT-registered. Its company number (CBE) is 0689.606.850.
Where is the registered office of Pharm.Assy?
According to the CBE register, the registered office of Pharm.Assy is in 1780 Wemmel.
What is the equity of Pharm.Assy?
At the close of the 2025 financial year, the equity of Pharm.Assy amounts to 149,646 €, a solvency of 55.6% of total assets.
How many people work at Pharm.Assy?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharm.Assy?
The register lists 1 active mandates at Pharm.Assy. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharm.Assy
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →